SPONSOR

University of Wisconsin, Madison

Total Trials

Recruiting

Phases

Phase 1, Phase 4, Phase 3, Phase 2

Conditions studied: Healthy Psychedelic Experiences Vagus Nerve Stimulation Xerostomia Graft-versus-host-disease Sjogren's Disease High-need, High-complexity Ovarian Cancer Cognitive Change Anxiety

University of Wisconsin, Madison is a clinical research sponsor with 22 registered studies on ClinicalTrials.gov, of which 22 are actively recruiting participants. Research covers conditions including Healthy, Psychedelic Experiences, Vagus Nerve Stimulation, Xerostomia.

The trial portfolio spans Phase 1, Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Wisconsin, Madison

How many clinical trials has University of Wisconsin, Madison sponsored?

ClinicalMetric currently tracks 22 clinical trials sponsored by University of Wisconsin, Madison, of which 22 are actively recruiting participants. These trials cover conditions including Healthy, Psychedelic Experiences, Vagus Nerve Stimulation. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Wisconsin, Madison research focus on?

University of Wisconsin, Madison clinical trials span Healthy, Psychedelic Experiences, Vagus Nerve Stimulation, Xerostomia, Graft-versus-host-disease, and additional conditions. The research pipeline includes Phase 1, Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Wisconsin, Madison clinical trial?

To participate in a University of Wisconsin, Madison trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Wisconsin, Madison trials with current recruitment status updated daily.

University of Wisconsin, Madison

Frequently Asked Questions — University of Wisconsin, Madison

Clinical Trials by University of Wisconsin, Madison

The ENHANCE Study: taVNS and Psilocybin

Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia

Implementation of a Primary Hospital Provider (PHP) Team

Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers

Music Interventions During Wide-Awake Hand Surgery

In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)

Storytelling and Mindfulness for Graduate Student Wellbeing

The Options 2 Study

18F-FLUC PET/MR in Patients With Brain Mets

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Study of 18F-FFNP Breast PET/MRI

Evaluating the Impacts of Informal Tick and Tickborne Disease Educational Tools on Children

Effect of TXA on Reducing Bruising After Filler Injection

The Avenues Study: Dual Use Cessation

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma

The RECAP2 Study: Midazolam and Psilocybin

Brain Health in Transgender Adults

Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes

Temporal Interference for Thalamocortical Activity and Network Modulation

Implementation of an Accessible Healthcare Model (ACHD STRONG): Comparing Nurse and Physician Lead Healthcare Transition Education in a RE-AIM Framework

Biomarkers Study in Infants With Prior Neonatal Brain Injury